Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Gushengtang Holdings Limited ( (HK:2273) ) has issued an update.
Gushengtang Holdings Limited announced the acquisition of DA ZHONG TANG, a Singapore-based company providing traditional Chinese medicine services and pharmaceutical retail. This acquisition aligns with Gushengtang’s strategy to expand its offline medical network and enhance market share in Singapore, while creating synergies with its existing healthcare platforms.
The most recent analyst rating on (HK:2273) stock is a Buy with a HK$46.00 price target. To see the full list of analyst forecasts on Gushengtang Holdings Limited stock, see the HK:2273 Stock Forecast page.
More about Gushengtang Holdings Limited
Gushengtang Holdings Limited operates in the healthcare industry, focusing on traditional Chinese medicine (TCM) services and pharmaceutical retail. The company is expanding its market presence, particularly in Singapore, through strategic acquisitions.
Average Trading Volume: 1,777,121
Technical Sentiment Signal: Sell
Current Market Cap: HK$6.87B
Learn more about 2273 stock on TipRanks’ Stock Analysis page.